[Report on the NIH Consensus Development Conference on Adjuvant Therapy of Breast Carcinoma].
Kaufmann
M
M
Universitäts-Frauenklinik Frankfurt/Main.
von Minckwitz
G
G
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008408:Mastectomy; D018714:Radiotherapy, Adjuvant
D018931:Antineoplastic Agents, Hormonal